Literature DB >> 30201131

Molecular epidemiology and clinical features of rhinovirus infections among hospitalized patients in a medical center in Taiwan.

Huei-Min Hung1, Shu-Li Yang2, Chih-Jung Chen1, Cheng-Hsun Chiu1, Chen-Yen Kuo1, Kuan-Ying A Huang1, Tzou-Yien Lin1, Yu-Chia Hsieh1, Yu-Nong Gong3, Kuo-Chien Tsao4, Yhu-Chering Huang5.   

Abstract

BACKGROUND: Human rhinovirus (HRV) can cause severe illnesses in hospitalized patients. However, there are no studies regarding the prevalence of HRV infection, particularly the recently identified HRV-C, in hospitalized patients reported from Taiwan.
METHODS: Respiratory specimens collected from 487 hospitalized patients in designated wards between 2013 and 2014 in a medical center in northern Taiwan were retrospectively detected for HRV. Positive specimens were further determined for genotyping. Medical charts of the HRV-positive patients were reviewed retrospectively.
RESULTS: Totally, 76 patients (15.6%) were HRV positive, of which 60 were pediatric patients. HRV-A was identified in 41 (54%) patients, HRV-B in 6 patients (7.9%) and HRV-C in 29 patients (38%). A total of 47 different genotypes were identified. HRV infections were predominant during fall and winter seasons. 21.1% were affected by HRV alone and 78.9% were found to be co-infected with other microorganisms. The detection rate of HRV in children (18.6%) was significantly higher than in adults (9.6%). Compared with pediatric patients, adult patients were significantly associated with underlying disease, Pneumocystis jirovesii pneumonia co-infection, a diagnosis of pneumonia, fatal outcome, hospital acquisition of HRV, antibiotics administration and requiring intensive care, while pediatric patients were significantly associated with viral co-infection.
CONCLUSIONS: HRV was a common cause of respiratory tract infection in Taiwan, particularly in pediatric patients. Eighty percent of HRV-infected inpatients had other microorganisms co-infection. Adult patients were more likely to be associated with a severe respiratory disease entity.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Hospitalized patients; Respiratory tract infection; Rhinovirus; Taiwan

Mesh:

Substances:

Year:  2018        PMID: 30201131     DOI: 10.1016/j.jmii.2018.08.009

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  13 in total

1.  Human virome in nasopharynx and tracheal secretion samples.

Authors:  Larissa da Costa Souza; Rosana Blawid; João Marcos Fagundes Silva; Tatsuya Nagata
Journal:  Mem Inst Oswaldo Cruz       Date:  2019-10-03       Impact factor: 2.743

2.  Molecular epidemiology and clinical impact of rhinovirus infections in adults during three epidemic seasons in 11 European countries (2007-2010).

Authors:  Kalina T Zlateva; Anneloes L van Rijn; Peter Simmonds; Frank E J Coenjaerts; Anton M van Loon; Theo J M Verheij; Jutte J C de Vries; Paul Little; Christopher C Butler; Erik W van Zwet; Herman Goossens; Margareta Ieven; Eric C J Claas
Journal:  Thorax       Date:  2020-08-20       Impact factor: 9.139

3.  Anxiety and depression due to 2019 SARS-CoV-2 among frontier healthcare workers in Kenya.

Authors:  David Onchonga; Enoch Ngetich; Wilbroda Makunda; Pius Wainaina; Diana Wangeshi; Prémusz Viktoria
Journal:  Heliyon       Date:  2021-02-23

4.  Viral Loads and Disease Severity in Children with Rhinovirus-Associated Illnesses.

Authors:  Maria I Sanchez-Codez; Katherine Moyer; Isabel Benavente-Fernández; Amy L Leber; Octavio Ramilo; Asuncion Mejias
Journal:  Viruses       Date:  2021-02-13       Impact factor: 5.048

5.  Phylogeography and phylogeny of Rhinoviruses collected from Severe Acute Respiratory Infection (SARI) cases over successive epidemic periods in Tunisia.

Authors:  Sondes Haddad-Boubaker; Cherif Ben Hamda; Kais Ghedira; Khaoula Mefteh; Aida Bouafsoun; Ilhem Boutiba-Ben Boubaker; Amin Slim; Khaled Menif; Henda Triki; Mohamed Ali Ben Hadj Kacem; Hanen Smaoui
Journal:  PLoS One       Date:  2021-11-22       Impact factor: 3.240

6.  The epidemiology and etiologies of respiratory tract infection in Northern Taiwan during the early phase of coronavirus disease 2019 (COVID-19) outbreak.

Authors:  Andrew Po-Liang Chen; Chien Chuang; Ying-Chi Huang; Ping-Feng Wu; Shiang-Fen Huang; Nai-Cheng Cheng; Yi-Tsung Lin; Su-Jung Chen; Ling-Ju Huang; Chia-Lin Lee; Hsin-Pai Chen; Yu-Jiun Chan; Fu-Der Wang
Journal:  J Microbiol Immunol Infect       Date:  2021-06-22       Impact factor: 4.399

7.  Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges.

Authors:  Chih-Cheng Lai; Tzu-Ping Shih; Wen-Chien Ko; Hung-Jen Tang; Po-Ren Hsueh
Journal:  Int J Antimicrob Agents       Date:  2020-02-17       Impact factor: 5.283

Review 8.  Recent advances in the detection of respiratory virus infection in humans.

Authors:  Naru Zhang; Lili Wang; Xiaoqian Deng; Ruiying Liang; Meng Su; Chen He; Lanfang Hu; Yudan Su; Jing Ren; Fei Yu; Lanying Du; Shibo Jiang
Journal:  J Med Virol       Date:  2020-02-04       Impact factor: 2.327

Review 9.  Understanding Rhinovirus Circulation and Impact on Illness.

Authors:  Camille Esneau; Alexandra Cate Duff; Nathan W Bartlett
Journal:  Viruses       Date:  2022-01-13       Impact factor: 5.048

10.  Human Rhinoviruses in Adult Patients in a Tertiary Care Hospital in Germany: Molecular Epidemiology and Clinical Significance.

Authors:  Philipp Golke; Mario Hönemann; Sandra Bergs; Uwe Gerd Liebert
Journal:  Viruses       Date:  2021-10-08       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.